M. Markova and G. Hristov, “Reporting of R&D Costs Under IAS 38 – The Case of Biopharmaceutical Companies”, НТ, no. 4, pp. 57–65, Jan. 2023, doi: https://doi.org/10.37075/RP.2022.4.04.